Global Blood Therapeutics, Inc. GBT
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 4.62B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -29.14
- Beta
- 0.46
- Short ratio
- 2.11
- Inst. own
- 111.41%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2022
- 50-d avg
- 63.70
- 200-d avg
- 38.56
- 1y target
- 64.50
News
8 months ago defenseworld.net
BMTC Group (TSE:GBT) Stock Price Crosses Below 50-Day Moving Average – What’s Next?
BMTC Group Inc. (TSE: GBT - Get Free Report) crossed below its 50 day moving average during trading on Friday. The stock has a 50 day moving average of C$12.98 and traded as low as C$12.80. BMTC…
4 years ago seekingalpha.com
Global Blood Therapeutics: Pfizer Acquisition Signals Increasing M/A Deals
After a slow first half, merger and acquisition deals are heating up for the remainder of 2022. In the efforts to boost its presence in rare hematology, Pfizer recently announced it is acquiring…
4 years ago businesswire.com
GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Global Blood…
4 years ago prnewswire.com
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates AAWW, GBT, CYBE, AVLR
NEW YORK , Aug. 22, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or…
4 years ago prnewswire.com
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates GBT, AVLR, CYBE, SBCF
NEW YORK , Aug. 15, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or…
4 years ago marketwatch.com
Get ready for more merger mania in pharma sector the rest of the year
Pfizer Inc.'s PFE, +0.24% $5.4 billion acquisition of Global Blood Therapeutics Inc. GBT, +0.02% is the latest sign that cash-flush drug makers are ready to jump back into dealmaking.
4 years ago zacks.com
Global Blood (GBT) to be Acquired by Pfizer, Misses on Earnings
Global Blood (GBT) is set to be acquired by Pfizer for around $5.4 billion. The company missed estimates for earnings while beating the same for revenues in the second quarter of 2022.
4 years ago invezz.com
Pfizer is acquiring Global Blood Therapeutics
Pfizer Inc (NYSE: PFE) has executed a definitive merger agreement with Global Blood Therapeutics Inc (NASDAQ: GBT), whereby Pfizer will acquire the biopharmaceutical corporation dedicated to the…
4 years ago proactiveinvestors.co.uk
Pfizer to buy Global Blood Therapeutics for US$5.4bn
Pfizer Inc (NYSE:PFE) is to pay US$5.4bn in cash to acquire sickle cell disease drugmaker Global Blood Therapeutics, Inc (NASDAQ:GBT) (GBT) as the pharma major looks to leverage the booming revenue…
4 years ago prnewswire.com
SHAREHOLDER ALERT: Weiss Law Investigates Global Blood Therapeutics, Inc.
NEW YORK , Aug. 8, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Global Blood Therapeutics, Inc.…
4 years ago fool.com
Why Global Blood Therapeutics Stock Was Trouncing the Market Today
The blood-disorder specialist sells itself in a deal with an enterprise value of around $5.4 billion.
4 years ago investorplace.com
GBT Stock Alert: Pfizer Is Officially Acquiring Global Blood Therapeutics
Source: ra2 studio/Shutterstock Last week, Global Blood Therapeutics (NASDAQ: GBT ) stock was thrust into the spotlight on reports of a potential buyout bid from Pfizer (NYSE: PFE ). Today, though,…
4 years ago investors.com
Pfizer Inks $5.4 Billion Deal To Acquire Global Blood Therapeutics
Pfizer inked a $5.4 billion deal Monday to buy Global Blood Therapeutics, confirming rumors that sent GBT stock skyrocketing last week. The post Pfizer Inks $5.4 Billion Deal To Acquire Global Blood…
4 years ago barrons.com
Pfizer Buys Global Blood Therapeutics. How the Deal Could Solve Pipeline Worries.
Pfizer said it would pay $68.50 per share for Global Blood Therapeutics which sells a sickle cell disease treatment called Oxbryta
4 years ago pulse2.com
Why Pfizer (PFE) Is Buying Global Blood Therapeutics (GBT) For $5.4 Billion
Pfizer Inc. (PFE) announced it is buying Global Blood Therapeutics (GBT) for $5.4 billion. This is why.
4 years ago foxbusiness.com
Pfizer reaches $5.4B deal for Global Blood Therapeutics
The New York drugmaker is buying Global Blood Therapeutics, which sells a drug for sickle-cell disease and has two in development. It will pay $68.50 per share.
4 years ago marketwatch.com
Pfizer confirms to acquire Global Blood Therapeutics for $5.4 billion in deal that gives it access to sickle-cell disease treatment
Pfizer Inc. PFE, -1.18% has agreed to buy Global Blood Therapeutics Inc. [s :gbt] in a deal valued at $5.4 billion, the companies said Monday, confirming a report by the Wall Street Journal. Pfizer…
4 years ago reuters.com
Pfizer to buy Global Blood Therapeutics in $5.4 billion deal
Pfizer Inc said on Monday it has agreed to buy blood disorder drugmaker Global Blood Therapeutics in a $5.4 billion deal, as it looks to fortify its product pipeline.
4 years ago businesswire.com
Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology
NEW YORK & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the companies have entered into a definitive…
-
4 years ago benzinga.com
Earnings Scheduled For August 8, 2022
Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter.
-
4 years ago benzinga.com
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday
Gainers
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
During Monday's trading, 1214 companies set new 52-week lows.
-
4 years ago benzinga.com
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
-
4 years ago benzinga.com
Earnings Scheduled For February 23, 2022
Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter.
-
4 years ago benzinga.com
Earnings Scheduled For November 4, 2021
Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
-
5 years ago benzinga.com
Earnings Scheduled For August 3, 2021
Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to report earnings for its second quarter.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Before 10 a.m. ET Thursday, 42 stocks made new 52-week lows.
-
5 years ago benzinga.com
Earnings Scheduled For May 5, 2021
Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter.
-
5 years ago benzinga.com
Earnings Scheduled For February 24, 2021
Companies Reporting Before The Bell • Pinnacle West Capital (NYSE:PNW) is expected to report quarterly earnings at $0.04 per share on revenue of $715.74 million.
-
5 years ago benzinga.com
Earnings Scheduled For November 5, 2020
Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stock (AMEX:BRG) is expected to report quarterly loss at $0.64 per share on revenue of $52.59 million.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Stocks That Hit 52-Week Highs On Friday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Thursday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Stocks That Hit 52-Week Highs On Friday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Thursday
-
6 years ago benzinga.com
26 Stocks Moving in Wednesday's Pre-Market Session
26 Stocks Moving in Wednesday's Pre-Market Session
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Stocks That Hit 52-Week Highs On Friday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Thursday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday
-
8 years ago benzinga.com
Mid-Day Market Update: Dow Down Over 200 Points; Affimed Shares Plummet
Mid-Day Market Update: Dow Down Over 200 Points; Affimed Shares Plummet
-
8 years ago benzinga.com
Oppenheimer Serves Up 29 Top Stock Ideas For January
Oppenheimer Serves Up 29 Top Stock Ideas For January
-
8 years ago benzinga.com
Benzinga's Top Upgrades, Downgrades For December 1, 2017
Benzinga's Top Upgrades, Downgrades For December 1, 2017
-
8 years ago benzinga.com
Oppenheimer's Top Stock Picks For December
Oppenheimer's Top Stock Picks For December
-
9 years ago benzinga.com
Benzinga's Top Upgrades, Downgrades For March 16, 2017
Benzinga's Top Upgrades, Downgrades For March 16, 2017